Cargando…

Noncanonical NF-κB in Cancer

The NF-κB pathway is a critical regulator of immune responses and is often dysregulated in cancer. Two NF-κB pathways have been described to mediate these responses, the canonical and the noncanonical. While understudied compared to the canonical NF-κB pathway, noncanonical NF-κB and its components...

Descripción completa

Detalles Bibliográficos
Autores principales: Tegowski, Matthew, Baldwin, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027307/
https://www.ncbi.nlm.nih.gov/pubmed/29874793
http://dx.doi.org/10.3390/biomedicines6020066
_version_ 1783336581464064000
author Tegowski, Matthew
Baldwin, Albert
author_facet Tegowski, Matthew
Baldwin, Albert
author_sort Tegowski, Matthew
collection PubMed
description The NF-κB pathway is a critical regulator of immune responses and is often dysregulated in cancer. Two NF-κB pathways have been described to mediate these responses, the canonical and the noncanonical. While understudied compared to the canonical NF-κB pathway, noncanonical NF-κB and its components have been shown to have effects, usually protumorigenic, in many different cancer types. Here, we review noncanonical NF-κB pathways and discuss its important roles in promoting cancer. We also discuss alternative NF-κB-independent functions of some the components of noncanonical NF-κB signaling. Finally, we discuss important crosstalk between canonical and noncanonical signaling, which blurs the two pathways, indicating that understanding the full picture of NF-κB regulation is critical to deciphering how this broad pathway promotes oncogenesis.
format Online
Article
Text
id pubmed-6027307
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60273072018-07-13 Noncanonical NF-κB in Cancer Tegowski, Matthew Baldwin, Albert Biomedicines Review The NF-κB pathway is a critical regulator of immune responses and is often dysregulated in cancer. Two NF-κB pathways have been described to mediate these responses, the canonical and the noncanonical. While understudied compared to the canonical NF-κB pathway, noncanonical NF-κB and its components have been shown to have effects, usually protumorigenic, in many different cancer types. Here, we review noncanonical NF-κB pathways and discuss its important roles in promoting cancer. We also discuss alternative NF-κB-independent functions of some the components of noncanonical NF-κB signaling. Finally, we discuss important crosstalk between canonical and noncanonical signaling, which blurs the two pathways, indicating that understanding the full picture of NF-κB regulation is critical to deciphering how this broad pathway promotes oncogenesis. MDPI 2018-06-05 /pmc/articles/PMC6027307/ /pubmed/29874793 http://dx.doi.org/10.3390/biomedicines6020066 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tegowski, Matthew
Baldwin, Albert
Noncanonical NF-κB in Cancer
title Noncanonical NF-κB in Cancer
title_full Noncanonical NF-κB in Cancer
title_fullStr Noncanonical NF-κB in Cancer
title_full_unstemmed Noncanonical NF-κB in Cancer
title_short Noncanonical NF-κB in Cancer
title_sort noncanonical nf-κb in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027307/
https://www.ncbi.nlm.nih.gov/pubmed/29874793
http://dx.doi.org/10.3390/biomedicines6020066
work_keys_str_mv AT tegowskimatthew noncanonicalnfkbincancer
AT baldwinalbert noncanonicalnfkbincancer